Alzheimer’s Drug Discovery Foundation Supports ADispell Technology With A Grant To Advance Novel Drug Candidates For …
Tuesday, March 22nd, 2011The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $170,750 to ADispell Inc. to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer’s Disease.
Read the original:
... continue reading